Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

I-tech - Big Q2 miss halts sales growth

22 augusti 2025

<a id="bm-comp-9402b9b8-2e45-4fba-ac09-862d337f307c" name="bm-comp-9402b9b8-2e45-4fba-ac09-862d337f307c" class="BMCustomAnchor"></a><table><tr><td bm-component-id="9402b9b8-2e45-4fba-ac09-862d337f307c" style="vertical-align: top; width:100.000000%;"><ul><li>Sales -39<font color="#000000">% vs. ABGSCe, EBIT SEK 5m vs. ABGSCe 16m</font></li><li>Weak Q2 due to inventory build-up following strong Q4/Q1</li><li>Gross margin continues to improve (59% vs. ABGSCe 56%)</li></ul></td></tr></table><a id="bm-comp-18417156-6821-477e-92c5-3b4cf022fce7" name="bm-comp-18417156-6821-477e-92c5-3b4cf022fce7" class="BMCustomAnchor"></a><table><tr><td bm-component-id="18417156-6821-477e-92c5-3b4cf022fce7" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Weaker Q2 than expected</h3><p>Sales came in lower than expected at SEK 32m (-39% vs. ABGSCe 52m), -26% y-o-y (-17% org. vs. ABGSCe 48%). The company writes that the lower sales are mainly due to natural quarterly variation, as well as strong sales in Q4'24 and Q1'25, contributing to inventory build-up among customers. As a result of lower sales, EBIT came in lower at SEK 4.7m (vs. ABGSCe 16m), for a margin of +15% (ABGSCe +30%). On a positive note, the gross margin continued to improve in the quarter and was 59% (vs. ABGSCe 56%). However, operating expenses rose in the quarter, mainly from costs linked to regulatory process (unspecified, estimated at SEK 1.8m) and increased personnel expenses following staff reinforcements. FCF lease adj. came in at SEK 2.7m (-61% vs. ABGSCe 6.9m).</p><h3 class="bm-h3">Estimates and outlook</h3><p>On numbers alone, '25e-'27e sales change by -9%, and EBIT adj. changes by -18%. Management writes that the global macro for shipping remains broadly positive. However, the company highlights one customer that is working down high inventory, which we believe could suppress near-term sales. Regarding the ongoing regulatory process, the company writes that it has met with the Commissioner's Cabinet to provide feedback on factual errors in the Selektope re-registration case. The company expects the outcome of the meeting to positively influence the next step in the process, which is the quarterly meeting of the Standing Committee on Biocidal Products (SCPB) in September.</p><h3 class="bm-h3">Valuation</h3><p>The share has returned +18% L3M (vs. peer median -3% and OMXSSMAC +12%), and is currently trading at 21x-14x '25e-'27e P/E on our pre-report estimates vs. the peer median of 47x-20x. <font color="#212529"><font style="background-color:#ffffff;"><font style="background-color:#ffffff;">The company will host a <a data-bm-trackable="false" href="https://www.finwire.tv/webcast/i-tech/q2-2025/" style="box-sizing:border-box; font-family:Arial, &quot;Unifont Calibri&quot;, &quot;Unifont Helvetica&quot;, &quot;Unifont Gotham&quot;, &quot;Unifont Arial&quot;, Unifont !important; color:#007bff; text-decoration:none;" target="_blank">presentation</a> of the Q2 results at</font></font></font> <font color="#000000"><font style="background-color:#ffffff;"><font style="background-color:#ffffff;"><font style="background-color:#ffffff;">10:30 CET.</font></font></font></font></p></td></tr></table><a id="bm-comp-29596adb-881c-4c1d-92f1-706b6aa026e5" name="bm-comp-29596adb-881c-4c1d-92f1-706b6aa026e5" class="BMCustomAnchor"></a><table><tr><td bm-component-id="29596adb-881c-4c1d-92f1-706b6aa026e5" style="vertical-align: top; width:100.000000%;"><table id="bm-img-283cdb52-c2b3-4547-b2fa-cafc3a145cb2" class="bm-img-table xslt-img-empty xslt-img-include"><tr><td class="xslt-img-caption">Deviation table</td></tr><tr><td><img bm-img-encrypt="283cdb52-c2b3-4547-b2fa-cafc3a145cb2" bm-img-original-height="512" bm-img-original-width="645" bm-img-svg="image:image_upload/89863_01db62cd-ed97-4fb2-adc8-c069be95a581.svg" bm-img-width-hint="88.72%" id="bm-id-283cdb52-c2b3-4547-b2fa-cafc3a145cb2" src="https://abgsc.bluematrix.com/images/image_upload/89863_01db62cd-ed97-4fb2-adc8-c069be95a581_645.png" svg="/nas/web/clients/abgsc/images/image_upload/89863_01db62cd-ed97-4fb2-adc8-c069be95a581.svg" width="645" alt="" title="" /></td></tr><tr><td class="xslt-img-source">Source: ABG Sundal Collier Estimates, Company Data</td></tr></table></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2025-08-27 Inission - Q2 likely marked the R12m EBITA trough Inission Analys
2025-08-27 BTS Group - North America turnaround in focus BTS Group Analys
2025-08-27 INVISIO - Positive outlook comments from peers INVISIO Analys
2025-08-27 Eolus Vind - Profitability facing headwinds Eolus Vind Analys
2025-08-27 Inission - Enedo the culprit of weaker Q2 EBITA Inission Analys
2025-08-26 Medicover - A "charmingly aggressive" CEO Medicover Analys
2025-08-26 Gentoo Media - Top-line challenges remain Gentoo Media Analys
2025-08-26 Catella - Ready to spring into action Catella Analys
2025-08-26 Impact Coatings - Preparing for market recovery Impact Coat.. Analys
2025-08-26 Ogunsen - Set to grow once the market improves Ogunsen Analys
2025-08-26 Gentoo Media - Soft Q2 and FY guidance downgrade Gentoo Media Analys
2025-08-26 Eolus Vind - Profitability impacted by project delay Eolus Vind Analys
2025-08-25 Ascelia Pharma - Ready for a decisive year Ascelia Pharma Analys
2025-08-24 I-tech - A pause, not a stop I-tech Analys
2025-08-24 Generic - Communication flows, margin grows Generic Analys
2025-08-24 Clavister - Scaling towards positive EBIT Clavister Analys
2025-08-22 Byggmästaren - Several promising developments Byggmästaren Analys
2025-08-22 Ogunsen - Sales beat but pressured profitability Ogunsen Analys
2025-08-22 Impact Coatings - Continued cautious market Impact Coat.. Analys
2025-08-22 I-tech - Big Q2 miss halts sales growth I-tech Analys